MSP Recovery Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

DB:CN5 Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
06 Nov 24Sell€106,549Palantir Technologies Inc., Investment ArmCompany38,334.24€3.02
01 Nov 24Sell€78,737Palantir Technologies Inc., Investment ArmCompany30,983.28€2.82
28 Aug 24Buy€10,887John RuizIndividual2,000€5.44
22 Aug 24Buy€90,030John RuizIndividual14,424.8€6.24
21 Aug 24Buy€24,850John RuizIndividual4,000€6.21
20 Aug 24Buy€22,941John RuizIndividual4,000€5.74
19 Aug 24Buy€22,621John RuizIndividual4,000€5.66
16 Aug 24Buy€38,594John RuizIndividual6,720€5.74
03 Apr 24Sell€925,055Cano Health, Inc.Company36,146.2€25.59
02 Apr 24Sell€925,547Cano Health, Inc.Company45,595.04€20.43
28 Mar 24Sell€32,626Cano Health, Inc.Company2,028.52€16.20
26 Mar 24Sell€65,990Cano Health, Inc.Company3,844.08€17.32
21 Mar 24Sell€82,452Cano Health, Inc.Company4,720.56€17.73
18 Mar 24Sell€105,282Cano Health, Inc.Company5,879.48€18.17
13 Mar 24Sell€106,638Cano Health, Inc.Company5,232.28€21.47
08 Mar 24Sell€357,369Cano Health, Inc.Company15,670.36€23.30
05 Mar 24Buy€1,788,511Cano Health, Inc.Company66,716.2€28.30
05 Mar 24Sell€1,791,357Cano Health, Inc.Company66,716.2€28.30
04 Mar 24Buy€460,349John RuizIndividual17,543.84€26.24
29 Feb 24Sell€72,333Cano Health, Inc.Company3,775.52€19.43
26 Feb 24Sell€61,710Cano Health, Inc.Company3,290.32€18.90
21 Feb 24Sell€172,442Cano Health, Inc.Company9,010.08€19.42
16 Feb 24Sell€62,930Cano Health, Inc.Company3,355.52€18.75
15 Feb 24Sell€161,988Cano Health, Inc.Company8,849.84€18.82
12 Feb 24Sell€90,797Cano Health, Inc.Company4,996.92€18.33
07 Feb 24Sell€152,921Cano Health, Inc.Company8,002.28€21.38
05 Feb 24Sell€45,848Cano Health, Inc.Company2,134.2€21.48
02 Feb 24Sell€166,432Cano Health, Inc.Company6,627.52€25.48
30 Jan 24Sell€145,488Cano Health, Inc.Company5,489.96€27.91
26 Jan 24Sell€251,290Cano Health, Inc.Company9,164.76€27.61
23 Jan 24Sell€1,991,456Cano Health, Inc.Company63,857.24€32.07
19 Jan 24Sell€60,068Cano Health, Inc.Company2,065€29.86
16 Jan 24Sell€82,567Cano Health, Inc.Company2,395.96€35.11
11 Jan 24Sell€34,801Cano Health, Inc.Company996.56€34.92
10 Jan 24Sell€206,542Cano Health, Inc.Company5,041.92€43.79

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of CN5?
Owner TypeNumber of SharesOwnership Percentage
Private Companies36,0051.9%
VC/PE Firms119,4156.29%
Institutions134,7317.09%
Individual Insiders137,1307.22%
General Public1,472,71977.5%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 23.8%.


Top Shareholders

Top 25 shareholders own 22.42% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
6.29%
Palantir Technologies Inc., Investment Arm
119,415€996.2k52.6%100.0%
5.88%
John Ruiz
111,657€931.4k-29.1%no data
2.49%
BlackRock, Inc.
47,333€394.9k1,020%no data
2.48%
Corient Private Wealth LLC
47,083€392.8k15.5%no data
1.05%
Virage Recovery Participation Lp
20,005€166.9k0%no data
0.84%
Ruiz Group Holdings Limited, Llc
16,000€133.5k-14.3%no data
0.59%
Frank Quesada
11,212€93.5k0.01%no data
0.56%
Pin Oak Investment Advisors Inc
10,584€88.3k12.3%0.02%
0.42%
Ophir Sternberg
8,029€67.0k0%no data
0.39%
The Vanguard Group, Inc.
7,360€61.4k0%no data
0.36%
Yorkville Advisors Global LP
6,800€56.7k-27.7%0.19%
0.21%
Geode Capital Management, LLC
4,016€33.5k83.6%no data
0.18%
Virtu Financial LLC, Asset Management Arm
3,494€29.1k304%no data
0.16%
Thomas Hawkins
2,949€24.6k178%no data
0.095%
Tower Research Capital Europe Limited
1,806€15.1k57.2%no data
0.066%
Virage Capital Management LP
1,260€10.5k0%0.84%
0.052%
Marshall Wace LLP
997€8.3k0%no data
0.05%
Roger Meltzer
949€7.9k0%no data
0.05%
Michael Arrigo
944€7.9k0%no data
0.049%
Lionheart Capital LLC
932€7.8k0%85.75%
0.046%
Alan Rubenstein
880€7.3k0%no data
0.039%
Baader Bank AG, Asset Management Arm
736€6.1k0%no data
0.033%
Morgan Stanley, Investment Banking and Brokerage Investments
623€5.2k0%no data
0.028%
UBS Asset Management AG
535€4.5k0%no data
0.024%
State Street Global Advisors, Inc.
452€3.8k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/04 23:54
End of Day Share Price 2024/11/15 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

MSP Recovery, Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Joshua SieglerCantor Fitzgerald & Co.